GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » Capex-to-Revenue

Ananda Developments (AQSE:ANA) Capex-to-Revenue : 0.00 (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Ananda Developments's Capital Expenditure for the six months ended in Jul. 2023 was £0.00 Mil. Its Revenue for the six months ended in Jul. 2023 was £0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Ananda Developments Capex-to-Revenue Historical Data

The historical data trend for Ananda Developments's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Capex-to-Revenue Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Capex-to-Revenue
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Developments's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ananda Developments's Capex-to-Revenue falls into.



Ananda Developments Capex-to-Revenue Calculation

Ananda Developments's Capex-to-Revenue for the fiscal year that ended in Jan. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

Ananda Developments's Capex-to-Revenue for the quarter that ended in Jul. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (AQSE:ANA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Ananda Developments Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments Headlines

No Headlines